18F-FDG primary tumor uptake to improve N status prediction in cT1 non-metastatic non-small cell lung cancer: development and validation of a positron emission tomography model.

Fiche publication


Date publication

avril 2023

Journal

Frontiers in medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CHENARD Marie-Pierre, Pr FALCOZ Pierre-Emmanuel, Pr IMPERIALE Alessio


Tous les auteurs :
Morland D, Chiappetta M, Falcoz PE, Chenard MP, Annunziata S, Boldrini L, Lococo F, Imperiale A

Résumé

Occult lymph node involvement is a major issue in the management of non-small cell lung carcinoma (NSCLC), with an estimated prevalence of approximately 2.9-21.6% in 18F-FDG PET/CT series. The aim of the study is to construct a PET model to improve lymph node assessment.

Mots clés

FDG, NSCLC, lymph nodes, model, positron emission tomography

Référence

Front Med (Lausanne). 2023 04 26;10:1141636